← All trials
NCT04936711
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 12, 2021
- Primary completion
- Nov 30, 2021
- Completion date
- Nov 30, 2022
- First posted
- Jun 23, 2021
- Last posted
- Jun 23, 2021
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Norton Thoracic InstituteLead sponsor
- Norton Thoracic InstituteReponsible party - principal investigator
- St. Joseph's Hospital and Medical Center - Phoenix, ArizonaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.